Department of Surgery, University of Missouri School of Medicine, Columbia, MO, USA.
Surg Endosc. 2024 Jul;38(7):3866-3874. doi: 10.1007/s00464-024-10902-y. Epub 2024 Jun 3.
The primary aim of this study was to evaluate outcomes associated with concurrent hiatal hernia repair (CHHR) when performing a conversional or revisional vertical sleeve gastrectomy (VSG). CHHR is often necessary during VSG due to potential gastroesophageal reflux disease (GERD) development or obstructive symptoms.
The Metabolic and Bariatric Surgery Accreditation and Quality Improvement (MBSAQIP) participant use file was assessed for the years 2015-2020 for revisional/conversional VSG procedures. The presence of CHHR was used to create two groups. Propensity score matching (PSM) was performed with E-analysis.
There were 33,909 patients available, with 5986 undergoing the VSG procedure with CHHR. In the unmatched analysis, there was an increased frequency of patients being female (85.72 vs 83.30%; p < 0.001), having a history of GERD (38.01 vs 31.25%; p < 0.001), and being of older age (49.59 ± 10.97 vs 48.70 ± 10.83; p < 0.001). Patients undergoing VSG with CHHR experienced decreased sleep apnea (25.00 vs 28.84%; p < 0.001) and diabetes (14.27 vs 17.80%; p < 0.001). PSM yielded 5986 patient pairs. Matched patients with CHHR experienced increased operative time (115 min ± 53 vs 103 min ± 51; p < 0.001), increased risk of postoperative pneumonia (0.45 vs 0.15%; p = 0.005) and readmission (4.69 vs 3.58%; p = 0.002) within thirty days. However, patients undergoing CHHR with revisional or conversional VSG did not experience increased risk of death, postoperative bleeding, postoperative leak, or reoperations.
Despite a small association with increased postoperative pneumonia, the rate of complications in patients undergoing laparoscopic revisional/conversional VSG and CHHR are low. CHHR is a safe option when combined with the laparoscopic revisional/conversional VSG procedure in the early postoperative period.
本研究的主要目的是评估在进行常规或翻修垂直袖状胃切除术(VSG)时并发食管裂孔疝修复(CHHR)相关的结果。由于潜在的胃食管反流病(GERD)发展或梗阻症状,VSG 过程中通常需要进行 CHHR。
评估 2015 年至 2020 年代谢和减重外科认证和质量改进(MBSAQIP)参与者使用文件中翻修/常规 VSG 手术的资料。使用 CHHR 来创建两组。采用 E 分析进行倾向评分匹配(PSM)。
共有 33909 例患者,其中 5986 例行 VSG 联合 CHHR 手术。在未匹配分析中,女性患者的比例(85.72% vs. 83.30%;p<0.001)、GERD 病史(38.01% vs. 31.25%;p<0.001)和年龄较大(49.59±10.97 岁 vs. 48.70±10.83 岁;p<0.001)的患者比例增加。行 VSG 联合 CHHR 手术的患者睡眠呼吸暂停(25.00% vs. 28.84%;p<0.001)和糖尿病(14.27% vs. 17.80%;p<0.001)发生率降低。PSM 产生了 5986 对患者。接受 CHHR 治疗的匹配患者手术时间延长(115±53 分钟 vs. 103±51 分钟;p<0.001),术后肺炎风险增加(0.45% vs. 0.15%;p=0.005),术后 30 天内再入院率(4.69% vs. 3.58%;p=0.002)增加。然而,行腹腔镜翻修/常规 VSG 联合 CHHR 的患者并未增加死亡、术后出血、术后漏诊或再次手术的风险。
尽管术后肺炎的风险略有增加,但行腹腔镜翻修/常规 VSG 联合 CHHR 的患者并发症发生率较低。在术后早期,CHHR 与腹腔镜翻修/常规 VSG 联合是一种安全的选择。